Anna Campain

2.1k total citations
32 papers, 1.4k citations indexed

About

Anna Campain is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Anna Campain has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Anna Campain's work include Retinal Diseases and Treatments (11 papers), Retinal Imaging and Analysis (11 papers) and Retinal and Optic Conditions (9 papers). Anna Campain is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Retinal Imaging and Analysis (11 papers) and Retinal and Optic Conditions (9 papers). Anna Campain collaborates with scholars based in Australia, United Kingdom and Switzerland. Anna Campain's co-authors include Jean Yang, Mark C. Gillies, Ian L. McAllister, Brian J. Morris, Francine Z. Marques, Samantha Fraser‐Bell, Lyndell L. Lim, Godfrey Quin, Alex P. Hunyor and Robyn H. Guymer and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Hypertension.

In The Last Decade

Anna Campain

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Campain Australia 18 735 651 384 150 148 32 1.4k
Kiang-Teck J Yeo United States 11 795 1.1× 552 0.8× 488 1.3× 80 0.5× 41 0.3× 30 1.3k
Snježana Kaštelan Croatia 17 583 0.8× 335 0.5× 148 0.4× 40 0.3× 103 0.7× 67 990
Antonela Gverović Antunica Croatia 12 367 0.5× 158 0.2× 114 0.3× 29 0.2× 84 0.6× 22 561
Sotoodeh Abhary Australia 13 386 0.5× 257 0.4× 195 0.5× 47 0.3× 18 0.1× 24 729
Johanna Liinamaa Finland 15 404 0.5× 234 0.4× 172 0.4× 46 0.3× 24 0.2× 43 787
Annal D. Meleth United States 12 713 1.0× 402 0.6× 362 0.9× 10 0.1× 39 0.3× 16 1.1k
Ming Sun China 20 83 0.1× 115 0.2× 355 0.9× 46 0.3× 131 0.9× 49 938
Frank S Ong United States 15 79 0.1× 90 0.1× 274 0.7× 62 0.4× 74 0.5× 21 719
Antti Jylhä Finland 15 132 0.2× 101 0.2× 280 0.7× 97 0.6× 22 0.1× 30 589

Countries citing papers authored by Anna Campain

Since Specialization
Citations

This map shows the geographic impact of Anna Campain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Campain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Campain more than expected).

Fields of papers citing papers by Anna Campain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Campain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Campain. The network helps show where Anna Campain may publish in the future.

Co-authorship network of co-authors of Anna Campain

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Campain. A scholar is included among the top collaborators of Anna Campain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Campain. Anna Campain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wilkinson, Claire, et al.. (2023). Cross‐sectional survey of a convenience sample of Australians who use alcohol home delivery services. Drug and Alcohol Review. 42(5). 986–995. 11 indexed citations
4.
Campain, Anna, John C. Mulley, Blake Angell, et al.. (2023). <p>The Winter Strategy &ndash; a&nbsp;Multifaceted Integrated&nbsp;Care Intervention to&nbsp;Support People with Chronic&nbsp;and Complex Care Needs&nbsp;during the Australian&nbsp;Winter Period</p>. International Journal of Integrated Care. 23. 12–12. 1 indexed citations
5.
Armour, Carol, Laurent Billot, Ines Krass, et al.. (2022). Integrating Pharmacy and Registry Data Strengthens Clinical Assessments of Patient Adherence. Frontiers in Pharmacology. 13. 869162–869162. 1 indexed citations
6.
Coorey, Genevieve, Anna Campain, John C. Mulley, et al.. (2022). Utilisation of government-subsidised chronic disease management plans and cardiovascular care in Australian general practices. BMC Primary Care. 23(1). 157–157. 5 indexed citations
7.
Barthelmes, Daniel, Vuong Nguyen, Vincent Daïen, et al.. (2017). TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 38(1). 20–28. 71 indexed citations
8.
Barthelmes, Daniel, Anna Campain, Jennifer Arnold, et al.. (2016). Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration. British Journal of Ophthalmology. 100(12). 1640–1645. 35 indexed citations
9.
Fraser‐Bell, Samantha, Lyndell L. Lim, Anna Campain, et al.. (2016). Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology. 123(6). 1399–1401. 58 indexed citations
10.
Gillies, Mark C., Anna Campain, Daniel Barthelmes, et al.. (2015). Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration. Ophthalmology. 122(9). 1837–1845. 194 indexed citations
11.
Fraser‐Bell, Samantha, et al.. (2015). Patient experiences in retinal trials: a cross-sectional study. BMC Ophthalmology. 15(1). 80–80. 12 indexed citations
12.
Mehta, Hemal, Samantha Fraser‐Bell, Anna Campain, et al.. (2015). Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial. British Journal of Ophthalmology. 100(7). 1000–1004. 32 indexed citations
13.
Gillies, Mark C., Lyndell L. Lim, Anna Campain, et al.. (2014). A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema. Ophthalmology. 121(12). 2473–2481. 232 indexed citations
14.
Gillies, Mark C., Anna Campain, Richard Walton, et al.. (2014). Time to Initial Clinician-Reported Inactivation of Neovascular Age-Related Macular Degeneration Treated Primarily with Ranibizumab. Ophthalmology. 122(3). 589–594.e1. 21 indexed citations
15.
Barthelmes, Daniel, Richard Walton, Jennifer Arnold, et al.. (2014). Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration. Ophthalmology. 121(10). 2073–2074. 11 indexed citations
16.
Schramm, Sarah‐Jane, Anna Campain, Jean Yang, & Graham J. Mann. (2011). Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis. Journal of Investigative Dermatology. 132(2). 274–283. 43 indexed citations
17.
Campain, Anna, et al.. (2011). Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling. BMC Medical Genomics. 4(1). 27–27. 22 indexed citations
18.
Marques, Francine Z., Anna Campain, Maciej Tomaszewski, et al.. (2011). Gene Expression Profiling Reveals Renin mRNA Overexpression in Human Hypertensive Kidneys and a Role for MicroRNAs. Hypertension. 58(6). 1093–1098. 194 indexed citations
19.
Marques, Francine Z., Anna Campain, Pamela J. Davern, et al.. (2011). Genes Influencing Circadian Differences in Blood Pressure in Hypertensive Mice. PLoS ONE. 6(4). e19203–e19203. 24 indexed citations
20.
Campain, Anna & Jean Yang. (2010). Comparison study of microarray meta-analysis methods. BMC Bioinformatics. 11(1). 408–408. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiang-Teck J Yeo Breakdown of academic impact, for papers by Snježana Kaštelan Breakdown of academic impact, for papers by Antonela Gverović Antunica Breakdown of academic impact, for papers by Sotoodeh Abhary Breakdown of academic impact, for papers by Johanna Liinamaa Breakdown of academic impact, for papers by Annal D. Meleth Breakdown of academic impact, for papers by Ming Sun Breakdown of academic impact, for papers by Frank S Ong Breakdown of academic impact, for papers by Antti Jylhä
Rankless by CCL
2026